Paper funded by the Myrovlytis Trust published

Lu et al. (2011) report that FLCN-null cells are particularly sensitive to the drug mithramycin.

This work was funded by the Myrovlytis Trust, through a grant awarded to Professor Eamonn Maher at the University of Birmingham, UK.